Akèy › Kat vèt › Genzyme Corporation
Genzyme Corporation: sponso kat vèt (PERM)
Genzyme Corporation te depoze 11 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 10. Mwayèn salè yo ofri $135,491; mwayèn tan soti nan depozisyon jiska sètifikasyon: 469 jou.
Aplikasyon PERM11
Sètifye10
Salè medyan ofri$135,491
Mwayèn jou pou sètifikasyon469
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)1,567
Nan biznis depi1981
Adrès anplwayèCambridge, MA
Salè H-1B nan Genzyme Corporation →
Tit travay
| Tit travay | Aplikasyon PERM | Salè medyan |
|---|---|---|
| Director, Dupilumab Global Market Access & Pricing | 1 | $201,594 |
| Senior Medical Liaison | 1 | $149,074 |
| Scientist, Downstream Process, Development | 1 | $98,345 |
| Associate Director, Forecasting | 1 | $118,965 |
| Global Brand Manager, ASMD | 1 | $134,555 |
| Global Market Data Senior Manager | 1 | — |
| Global Dupixent Senior Financial Analyst | 1 | $136,427 |
| Data Scientist, Global Quality Digital Transformation | 1 | $144,040 |
| Director, Global Hemophilia Marketing | 1 | $219,357 |
| Process Engineer | 1 | $96,242 |
| Senior Associate Scientist | 1 | $85,842 |
Kote travay
Okipasyon
- Marketing Managers3
- Biochemists and Biophysicists2
- Data Scientists2
- Medical and Health Services Managers1
- Operations Research Analysts1
- Financial and Investment Analysts1
- Molecular and Cellular Biologists1
Dènye desizyon
| Tit travay | Salè baz | Kote | Soumèt | Deside | Estati | Jou |
|---|---|---|---|---|---|---|
| Senior Associate Scientist | $85,842–$122,500 | Waltham, MA | Nov 20, 2025 | Sep 21, 2026 | Sètifye | 305 |
| Process Engineer | $96,242–$136,250 | Framingham, MA | Sep 16, 2025 | Aug 13, 2026 | Sètifye | 331 |
| Director, Global Hemophilia Marketing | $219,357–$285,000 | Cambridge, MA | Aug 5, 2025 | Jul 23, 2026 | Sètifye | 352 |
| Data Scientist, Global Quality Digital Transformation | $144,040–$150,000 | Cambridge, MA | Nov 25, 2024 | Mar 31, 2026 | Sètifye, ekspiré | 491 |
| Global Dupixent Senior Financial Analyst | $136,427–$140,000 | Cambridge, MA | Oct 30, 2024 | Feb 27, 2026 | Sètifye, ekspiré | 485 |
| Global Market Data Senior Manager | $144,040–$171,237 | Cambridge, MA | Jul 3, 2024 | Nov 24, 2025 | Refize | — |
| Associate Director, Forecasting | $118,965–$198,275 | Cambridge, MA | Jul 17, 2024 | Nov 19, 2025 | Sètifye, ekspiré | 490 |
| Global Brand Manager, ASMD | $134,555–$170,000 | Cambridge, MA | Jul 16, 2024 | Nov 19, 2025 | Sètifye, ekspiré | 491 |
| Scientist, Downstream Process, Development | $98,345–$163,909 | Framingham, MA | Jun 21, 2024 | Sep 19, 2025 | Sètifye | 455 |
| Senior Medical Liaison | $149,074–$223,278 | Cambridge, MA | May 30, 2024 | Sep 4, 2025 | Sètifye | 462 |
| Director, Dupilumab Global Market Access & Pricing | $201,594–$280,066 | Cambridge, MA | Apr 17, 2024 | Aug 6, 2025 | Sètifye | 476 |
Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Sep 30, 2026).